Prognostic Value of Coronary Computed Tomographic Angiography in Diabetic Patients Without Known Coronary Artery Disease
Overview
Authors
Affiliations
Objective: Diabetic patients have a high prevalence of coronary artery disease (CAD), but timely diagnosis of CAD remains challenging. We assessed the ability of coronary computed tomography angiography (CCTA) to detect CAD in diabetic patients and to predict subsequent cardiac events.
Research Design And Methods: We analyzed 140 diabetic patients without known CAD undergoing CCTA; 1,782 patients without diabetes were used as a control group. Besides calcium scoring and the degree of the most severe stenosis, the atherosclerotic burden score counting the number of segments having either a nonstenotic plaque or a stenosis was recorded. The primary end point was a composite of hard cardiac events defined as all-cause death, nonfatal myocardial infarction, or unstable angina requiring hospitalization.
Results: During a mean follow-up of 33 months, there were seven events in the diabetic group and 24 events in the control group. The best predictor in diabetic patients was the atherosclerotic burden score: the annual event rate ranged from 0.5% for patients with <5 lesions to 9.6% for patients with >9 lesions, resulting in a hazard ratio (HR) of 1.3 (95% CI 1.1-1.7) for each additional lesion (P = 0.005). For comparison, in nondiabetic patients the annual event rate ranged from 0.3 to 2.2%, respectively, resulting in an HR of 1.2 (95% CI 1.1-1.3, P < 0.001). The atherosclerotic burden score improved the prognostic value of conventional risk factors significantly (P < 0.001).
Conclusions: In diabetic patients without known CAD, CCTA can identify a patient group at particularly high risk for subsequent hard cardiac events.
Presence of coronary artery disease in adults with newly detected diabetes mellitus.
Lai C, Chang B, Hwang L BMC Cardiovasc Disord. 2025; 25(1):76.
PMID: 39901120 PMC: 11789286. DOI: 10.1186/s12872-024-04463-0.
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024.
Diabetes Care. 2023; 47(Suppl 1):S179-S218.
PMID: 38078592 PMC: 10725811. DOI: 10.2337/dc24-S010.
Liu Z, Ding Y, Dou G, Yang X, Wang X, Shan D Atheroscler Plus. 2023; 44:10-17.
PMID: 36644667 PMC: 9833230. DOI: 10.1016/j.athplu.2021.07.021.
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023.
ElSayed N, Aleppo G, Aroda V, Bannuru R, Brown F, Bruemmer D Diabetes Care. 2022; 46(Suppl 1):S158-S190.
PMID: 36507632 PMC: 9810475. DOI: 10.2337/dc23-S010.
Jiang Y, Yang Z, Wang J, Shi R, Han P, Qian W Cardiovasc Diabetol. 2022; 21(1):259.
PMID: 36443722 PMC: 9706943. DOI: 10.1186/s12933-022-01700-8.